May your rights stay protected, your documentation stay thorough, and your recovery stay steady.
We dont touch research-grade molecules
Headaches occur in about 10% to 15% of users, most commonly during the first two weeks
If the taste appears in the early weeks or after dose adjustments, it is usually part of this adjustment phase and not a cause for concern
In previous studies, the incidence of thyroid dysfunction induced by pembrolizumab and nivolumab ranged from 5 to 30%, 1,2,3,4,21,22,23,24 and the wide range is possibly because the studies were not designed to detect thyroid dysfunction, or the definition of thyroid dysfunction varied among the studies
Longer plateaus: A plateau typically means your weight has stayed about the same for several weeks, even while youre taking tirzepatide consistently